grant

Dissecting the role of mirtrons in human cancers

Organization TEXAS TECH UNIVERSITYLocation LUBBOCK, UNITED STATESPosted 1 Apr 2024Deadline 31 Mar 2028
NIHUS FederalResearch GrantFY2025AddressAdoptedAlkaline PhosphataseAntigen PresentationBindingBinding SitesBiogenesisBiologicalBreast CancerBreast Cancer CellBreast Cancer cell lineBreast tumor cell lineBypassCRISPR approachCRISPR based approachCRISPR methodCRISPR methodologyCRISPR techniqueCRISPR technologyCRISPR toolsCRISPR-CAS-9CRISPR-based methodCRISPR-based techniqueCRISPR-based technologyCRISPR-based toolCRISPR/CAS approachCRISPR/Cas methodCRISPR/Cas technologyCRISPR/Cas9CRISPR/Cas9 technologyCancer TreatmentCancersCas nuclease technologyCell BodyCell Communication and SignalingCell LineCell SignalingCellLineCellsCellular Immune FunctionChemistryClustered Regularly Interspaced Short Palindromic Repeats approachClustered Regularly Interspaced Short Palindromic Repeats methodClustered Regularly Interspaced Short Palindromic Repeats methodologyClustered Regularly Interspaced Short Palindromic Repeats techniqueClustered Regularly Interspaced Short Palindromic Repeats technologyCombining SiteDKFZp547I0610DKFZp564I0682DNA-Dependent RNA PolymerasesDNA-Directed RNA PolymeraseDataDevelopmentDigestionDiseaseDisease ProgressionDisorderEctopic ExpressionEndocytosisEndosomesEnsureEnzyme GeneEnzymesEventExhibitsExoribonucleasesExposure toFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryG-QuadruplexG-Quadruplexes DNAG-Quartet StructuresG-QuartetsG-TetradsG4-DNAGenerationsGuanineGuanine NucleotidesGuanosineGuanosine PhosphatesHumanImmuneImmune DiseasesImmune DisordersImmune DysfunctionImmune System DiseasesImmune System DisorderImmune System DysfunctionImmune System and Related DisordersImmune responseImmunesImmunityImmunoglobulin Enhancer-Binding ProteinImmunologic DiseasesImmunological DiseasesImmunological DysfunctionImmunological System DysfunctionImmunomodulationInterruptionIntracellular Communication and SignalingKIAA0012Knock-outKnockoutKnowledgeLeadLibrariesLigand BindingLigandsLinkLiteratureLower OrganismMacrophageMalignant Breast NeoplasmMalignant CellMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMammaliaMammalsMediatingMethodologyMicroRNAsModern ManModificationMolecular InteractionMonitorNF-kBNF-kappa BNF-kappaBNFKBNon-Polyadenylated RNANormal CellNuclear Factor kappa BNuclear Transcription Factor NF-kBNucleotidesOrigin of LifePb elementPoly APoly(rA)PolymeraseProcessProductionPropertyProteinsRNARNA Gene ProductsRNA NucleasesRNA PolymerasesRNA SplicingRNA VirusesRNaseReactionReactive SiteReceptosomesRegulationReporterResearchResistanceRibonuclease Family ProteinRibonucleasesRibonucleic AcidRoleSignal TransductionSignal Transduction SystemsSignalingSiteSmall RNASortingSpectroscopySpectrum AnalysesSpectrum AnalysisSplicingStrains Cell LinesStructureTLR1TLR1 geneTLR1 proteinTLR1 receptorTLR7TLR7 geneTailTechnologyTestingTherapeuticTherapeutic InterventionToll-Like Receptor 1Toll-Like Receptor 7Toll/Interleukin-1 Receptor-LikeTranscription Factor NF-kBTumor PromotionWorkalkaline phosphomonoesteraseanti-cancer therapybiologicbiological signal transductionbreast tumor cellcancer cellcancer progressioncancer sub-typescancer subtypescancer therapycancer-directed therapycultured cell linecytokinedevelopmentalexosomeexperimentexperimental researchexperimental studyexperimentsfightingflow cytophotometrygene regulatory networkglycerophosphataseheavy metal Pbheavy metal leadhost responsehuman diseaseimmune functionimmune modulationimmune regulationimmune system responseimmunologic reactivity controlimmunomodulatoryimmunoregulationimmunoregulatoryimmunoresponseinhibitorintervention therapykappa B Enhancer Binding Proteinknock-downknockdownmalignancymalignant breast tumormiRNAneoplasm progressionneoplasm/cancerneoplastic progressionnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapynuclear factor kappa betanucleasepolyadenylatepreventpreventingresistantrsc786selective expressionselectively expressedsocial roletherapeutically effectivetumortumor progressionvector
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary/Abstract
Mirtrons are a new class of small RNAs. Previous findings show mirtrons are generated by splicing and

are less stable than canonical miRNAs. Thus, the expression of mirtrons is often negligible. Additionally, most

mirtrons exhibit distinct evolutionary properties relative to solo and mammals have way more mirtrons than…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Dissecting the role of mirtrons in human cancers — TEXAS TECH UNIVERSITY | UNITED STATES | Apr 2024 | Dev Procure